43 related articles for article (PubMed ID: 17644874)
1. The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
Afolabi H; Zhang BM; O'Shaughnessy M; Chertow GM; Lafayette R; Charu V
Am J Kidney Dis; 2024 Jan; 83(1):79-89. PubMed ID: 37739026
[TBL] [Abstract][Full Text] [Related]
2. Microscopic Hematuria in C3G and IC-MPGN.
Caravaca-Fontán F; Praga M
Nephrol Dial Transplant; 2024 Apr; ():. PubMed ID: 38688873
[No Abstract] [Full Text] [Related]
3. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
Häffner K; Michelfelder S; Pohl M
Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
[TBL] [Abstract][Full Text] [Related]
4. Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.
Zhang Y; Nester CM; Holanda DG; Marsh HC; Hammond RA; Thomas LJ; Meyer NC; Hunsicker LG; Sethi S; Smith RJ
J Am Soc Nephrol; 2013 Nov; 24(11):1820-9. PubMed ID: 23907509
[TBL] [Abstract][Full Text] [Related]
5. Causes of alternative pathway dysregulation in dense deposit disease.
Zhang Y; Meyer NC; Wang K; Nishimura C; Frees K; Jones M; Katz LM; Sethi S; Smith RJ
Clin J Am Soc Nephrol; 2012 Feb; 7(2):265-74. PubMed ID: 22223606
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of 98 children and adults with dense deposit disease.
Lu DF; Moon M; Lanning LD; McCarthy AM; Smith RJ
Pediatr Nephrol; 2012 May; 27(5):773-81. PubMed ID: 22105967
[TBL] [Abstract][Full Text] [Related]
7. Regulating complement in the kidney: insights from CFHR5 nephropathy.
Gale DP; Pickering MC
Dis Model Mech; 2011 Nov; 4(6):721-6. PubMed ID: 22065842
[TBL] [Abstract][Full Text] [Related]
8. Allelic variants of complement genes associated with dense deposit disease.
Abrera-Abeleda MA; Nishimura C; Frees K; Jones M; Maga T; Katz LM; Zhang Y; Smith RJ
J Am Soc Nephrol; 2011 Aug; 22(8):1551-9. PubMed ID: 21784901
[TBL] [Abstract][Full Text] [Related]
9. Dense deposit disease.
Smith RJ; Harris CL; Pickering MC
Mol Immunol; 2011 Aug; 48(14):1604-10. PubMed ID: 21601923
[TBL] [Abstract][Full Text] [Related]
10. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
11. New approaches to the treatment of dense deposit disease.
Smith RJ; Alexander J; Barlow PN; Botto M; Cassavant TL; Cook HT; de Córdoba SR; Hageman GS; Jokiranta TS; Kimberling WJ; Lambris JD; Lanning LD; Levidiotis V; Licht C; Lutz HU; Meri S; Pickering MC; Quigg RJ; Rops AL; Salant DJ; Sethi S; Thurman JM; Tully HF; Tully SP; van der Vlag J; Walker PD; Würzner R; Zipfel PF;
J Am Soc Nephrol; 2007 Sep; 18(9):2447-56. PubMed ID: 17675665
[TBL] [Abstract][Full Text] [Related]
12. Early presentation of membranoproliferative glomerulonephritis in Arab children.
Kari JA
Saudi Med J; 2003 Feb; 24(2):157-60. PubMed ID: 12682679
[TBL] [Abstract][Full Text] [Related]
13. A patient with membranoproliferative glomerulonephritis diagnosed by the third biopsy via endocapillary proliferative glomerulonephritis and focal membranoproliferative glomerulonephritis.
Kano K; Nishikura K; Kojima M; Yamada Y; Arisaka O; Tomita S; Shimotsuji T; Fujikawa Y; Inafuku S; Imakita M; Ueda Y
Clin Exp Nephrol; 2003 Jun; 7(2):157-62. PubMed ID: 14586735
[TBL] [Abstract][Full Text] [Related]
14. [Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Ueda H; Isimura E; Okuno S; Maekawa K; Izumotani T; Kim M; Matsumoto N; Fukumoto S; Imanishi Y; Emoto M; Shoji T; Wanibuchi H; Inaba M; Nishizawa Y
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):420-6. PubMed ID: 12073629
[TBL] [Abstract][Full Text] [Related]
15. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
Appel GB; Cook HT; Hageman G; Jennette JC; Kashgarian M; Kirschfink M; Lambris JD; Lanning L; Lutz HU; Meri S; Rose NR; Salant DJ; Sethi S; Smith RJ; Smoyer W; Tully HF; Tully SP; Walker P; Welsh M; Würzner R; Zipfel PF
J Am Soc Nephrol; 2005 May; 16(5):1392-403. PubMed ID: 15800116
[TBL] [Abstract][Full Text] [Related]
16. A descriptive study of individuals with membranoproliferative glomerulonephritis.
Lu DF; McCarthy AM; Lanning LD; Delaney C; Porter C
Nephrol Nurs J; 2007; 34(3):295-302; quiz 303. PubMed ID: 17644874
[TBL] [Abstract][Full Text] [Related]
17. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
